aluates Reports

$ 46445.0

Automative

Global Edoxaban API Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-26R7499

Global Edoxaban API Market Insights Forecast to 2028

BUY CHAPTERS

Global Edoxaban API Market Research Report 2025

Code: QYRE-Auto-26R7499

Report

June 2025

Pages:102

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Tecoland

FCDA

Uquifa

Glenmark Life Sciences

AlchemyPharm

Athos Chemicals

Jigs Chemical

Shanghaizehan biopharma technology

Inner Mongolia Jingdong Pharmaceutical

Shengda Pharmaceutical

Tianyu Pharm

Edoxaban API Market

The global market for Edoxaban API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Edoxaban is an oral anticoagulant drug which acts as a direct factor Xa inhibitor.

North American market for Edoxaban API is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Edoxaban API is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Edoxaban API include Tecoland, FCDA, UQUIFA, Glenmark Life Sciences, AlchemyPharm, Athos Chemicals, Jigs chemical, Shanghaizehan biopharma technology, Inner Mongolia Jingdong Pharmaceutical, Shengda Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Edoxaban API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Edoxaban API.

The Edoxaban API market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Edoxaban API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Edoxaban API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Edoxaban API Market Report

Report Metric	Details
Report Name	Edoxaban API Market
by Type	Min Purity Less Than 98% Min Purity 98%-99% Min Purity More Than 99%
by Application	Research Pharmaceutical
Production by Region	North America Europe China Japan India
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Tecoland, FCDA, UQUIFA, Glenmark Life Sciences, AlchemyPharm, Athos Chemicals, Jigs chemical, Shanghaizehan biopharma technology, Inner Mongolia Jingdong Pharmaceutical, Shengda Pharmaceutical, Tianyu Pharm
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Edoxaban API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Edoxaban API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Edoxaban API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Edoxaban API Market report?

Ans: The main players in the Edoxaban API Market are Tecoland, FCDA, UQUIFA, Glenmark Life Sciences, AlchemyPharm, Athos Chemicals, Jigs chemical, Shanghaizehan biopharma technology, Inner Mongolia Jingdong Pharmaceutical, Shengda Pharmaceutical, Tianyu Pharm

What are the Application segmentation covered in the Edoxaban API Market report?

Ans: The Applications covered in the Edoxaban API Market report are Research, Pharmaceutical

What are the Type segmentation covered in the Edoxaban API Market report?

Ans: The Types covered in the Edoxaban API Market report are Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%

1 Edoxaban API Market Overview

1.1 Product Definition

1.2 Edoxaban API by Type

1.2.1 Global Edoxaban API Market Value Growth Rate Analysis by Type: 2024 VS 2031

1.2.2 Min Purity Less Than 98%

1.2.3 Min Purity 98%-99%

1.2.4 Min Purity More Than 99%

1.3 Edoxaban API by Application

1.3.1 Global Edoxaban API Market Value Growth Rate Analysis by Application: 2024 VS 2031

1.3.2 Research

1.3.3 Pharmaceutical

1.4 Global Market Growth Prospects

1.4.1 Global Edoxaban API Production Value Estimates and Forecasts (2020-2031)

1.4.2 Global Edoxaban API Production Capacity Estimates and Forecasts (2020-2031)

1.4.3 Global Edoxaban API Production Estimates and Forecasts (2020-2031)

1.4.4 Global Edoxaban API Market Average Price Estimates and Forecasts (2020-2031)

1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

2.1 Global Edoxaban API Production Market Share by Manufacturers (2020-2025)

2.2 Global Edoxaban API Production Value Market Share by Manufacturers (2020-2025)

2.3 Global Key Players of Edoxaban API, Industry Ranking, 2023 VS 2024

2.4 Global Edoxaban API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.5 Global Edoxaban API Average Price by Manufacturers (2020-2025)

2.6 Global Key Manufacturers of Edoxaban API, Manufacturing Base Distribution and Headquarters

2.7 Global Key Manufacturers of Edoxaban API, Product Offered and Application

2.8 Global Key Manufacturers of Edoxaban API, Date of Enter into This Industry

2.9 Edoxaban API Market Competitive Situation and Trends

2.9.1 Edoxaban API Market Concentration Rate

2.9.2 Global 5 and 10 Largest Edoxaban API Players Market Share by Revenue

2.10 Mergers & Acquisitions, Expansion

3 Edoxaban API Production by Region

3.1 Global Edoxaban API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.2 Global Edoxaban API Production Value by Region (2020-2031)

3.2.1 Global Edoxaban API Production Value by Region (2020-2025)

3.2.2 Global Forecasted Production Value of Edoxaban API by Region (2026-2031)

3.3 Global Edoxaban API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.4 Global Edoxaban API Production Volume by Region (2020-2031)

3.4.1 Global Edoxaban API Production by Region (2020-2025)

3.4.2 Global Forecasted Production of Edoxaban API by Region (2026-2031)

3.5 Global Edoxaban API Market Price Analysis by Region (2020-2025)

3.6 Global Edoxaban API Production and Value, Year-over-Year Growth

3.6.1 North America Edoxaban API Production Value Estimates and Forecasts (2020-2031)

3.6.2 Europe Edoxaban API Production Value Estimates and Forecasts (2020-2031)

3.6.3 China Edoxaban API Production Value Estimates and Forecasts (2020-2031)

3.6.4 Japan Edoxaban API Production Value Estimates and Forecasts (2020-2031)

3.6.5 India Edoxaban API Production Value Estimates and Forecasts (2020-2031)

4 Edoxaban API Consumption by Region

4.1 Global Edoxaban API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

4.2 Global Edoxaban API Consumption by Region (2020-2031)

4.2.1 Global Edoxaban API Consumption by Region (2020-2025)

4.2.2 Global Edoxaban API Forecasted Consumption by Region (2026-2031)

4.3 North America

4.3.1 North America Edoxaban API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.3.2 North America Edoxaban API Consumption by Country (2020-2031)

4.3.3 U.S.

4.3.4 Canada

4.4 Europe

4.4.1 Europe Edoxaban API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.4.2 Europe Edoxaban API Consumption by Country (2020-2031)

4.4.3 Germany

4.4.4 France

4.4.5 U.K.

4.4.6 Italy

4.4.7 Russia

4.5 Asia Pacific

4.5.1 Asia Pacific Edoxaban API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031

4.5.2 Asia Pacific Edoxaban API Consumption by Region (2020-2031)

4.5.3 China

4.5.4 Japan

4.5.5 South Korea

4.5.6 China Taiwan

4.5.7 Southeast Asia

4.5.8 India

4.6 Latin America, Middle East & Africa

4.6.1 Latin America, Middle East & Africa Edoxaban API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.6.2 Latin America, Middle East & Africa Edoxaban API Consumption by Country (2020-2031)

4.6.3 Mexico

4.6.4 Brazil

4.6.5 Turkey

4.6.6 GCC Countries

5 Segment by Type

5.1 Global Edoxaban API Production by Type (2020-2031)

5.1.1 Global Edoxaban API Production by Type (2020-2025)

5.1.2 Global Edoxaban API Production by Type (2026-2031)

5.1.3 Global Edoxaban API Production Market Share by Type (2020-2031)

5.2 Global Edoxaban API Production Value by Type (2020-2031)

5.2.1 Global Edoxaban API Production Value by Type (2020-2025)

5.2.2 Global Edoxaban API Production Value by Type (2026-2031)

5.2.3 Global Edoxaban API Production Value Market Share by Type (2020-2031)

5.3 Global Edoxaban API Price by Type (2020-2031)

6 Segment by Application

6.1 Global Edoxaban API Production by Application (2020-2031)

6.1.1 Global Edoxaban API Production by Application (2020-2025)

6.1.2 Global Edoxaban API Production by Application (2026-2031)

6.1.3 Global Edoxaban API Production Market Share by Application (2020-2031)

6.2 Global Edoxaban API Production Value by Application (2020-2031)

6.2.1 Global Edoxaban API Production Value by Application (2020-2025)

6.2.2 Global Edoxaban API Production Value by Application (2026-2031)

6.2.3 Global Edoxaban API Production Value Market Share by Application (2020-2031)

6.3 Global Edoxaban API Price by Application (2020-2031)

7 Key Companies Profiled

7.1 Tecoland

7.1.1 Tecoland Edoxaban API Company Information

7.1.2 Tecoland Edoxaban API Product Portfolio

7.1.3 Tecoland Edoxaban API Production, Value, Price and Gross Margin (2020-2025)

7.1.4 Tecoland Main Business and Markets Served

7.1.5 Tecoland Recent Developments/Updates

7.2 FCDA

7.2.1 FCDA Edoxaban API Company Information

7.2.2 FCDA Edoxaban API Product Portfolio

7.2.3 FCDA Edoxaban API Production, Value, Price and Gross Margin (2020-2025)

7.2.4 FCDA Main Business and Markets Served

7.2.5 FCDA Recent Developments/Updates

7.3 UQUIFA

7.3.1 UQUIFA Edoxaban API Company Information

7.3.2 UQUIFA Edoxaban API Product Portfolio

7.3.3 UQUIFA Edoxaban API Production, Value, Price and Gross Margin (2020-2025)

7.3.4 UQUIFA Main Business and Markets Served

7.3.5 UQUIFA Recent Developments/Updates

7.4 Glenmark Life Sciences

7.4.1 Glenmark Life Sciences Edoxaban API Company Information

7.4.2 Glenmark Life Sciences Edoxaban API Product Portfolio

7.4.3 Glenmark Life Sciences Edoxaban API Production, Value, Price and Gross Margin (2020-2025)

7.4.4 Glenmark Life Sciences Main Business and Markets Served

7.4.5 Glenmark Life Sciences Recent Developments/Updates

7.5 AlchemyPharm

7.5.1 AlchemyPharm Edoxaban API Company Information

7.5.2 AlchemyPharm Edoxaban API Product Portfolio

7.5.3 AlchemyPharm Edoxaban API Production, Value, Price and Gross Margin (2020-2025)

7.5.4 AlchemyPharm Main Business and Markets Served

7.5.5 AlchemyPharm Recent Developments/Updates

7.6 Athos Chemicals

7.6.1 Athos Chemicals Edoxaban API Company Information

7.6.2 Athos Chemicals Edoxaban API Product Portfolio

7.6.3 Athos Chemicals Edoxaban API Production, Value, Price and Gross Margin (2020-2025)

7.6.4 Athos Chemicals Main Business and Markets Served

7.6.5 Athos Chemicals Recent Developments/Updates

7.7 Jigs chemical

7.7.1 Jigs chemical Edoxaban API Company Information

7.7.2 Jigs chemical Edoxaban API Product Portfolio

7.7.3 Jigs chemical Edoxaban API Production, Value, Price and Gross Margin (2020-2025)

7.7.4 Jigs chemical Main Business and Markets Served

7.7.5 Jigs chemical Recent Developments/Updates

7.8 Shanghaizehan biopharma technology

7.8.1 Shanghaizehan biopharma technology Edoxaban API Company Information

7.8.2 Shanghaizehan biopharma technology Edoxaban API Product Portfolio

7.8.3 Shanghaizehan biopharma technology Edoxaban API Production, Value, Price and Gross Margin (2020-2025)

7.8.4 Shanghaizehan biopharma technology Main Business and Markets Served

7.8.5 Shanghaizehan biopharma technology Recent Developments/Updates

7.9 Inner Mongolia Jingdong Pharmaceutical

7.9.1 Inner Mongolia Jingdong Pharmaceutical Edoxaban API Company Information

7.9.2 Inner Mongolia Jingdong Pharmaceutical Edoxaban API Product Portfolio

7.9.3 Inner Mongolia Jingdong Pharmaceutical Edoxaban API Production, Value, Price and Gross Margin (2020-2025)

7.9.4 Inner Mongolia Jingdong Pharmaceutical Main Business and Markets Served

7.9.5 Inner Mongolia Jingdong Pharmaceutical Recent Developments/Updates

7.10 Shengda Pharmaceutical

7.10.1 Shengda Pharmaceutical Edoxaban API Company Information

7.10.2 Shengda Pharmaceutical Edoxaban API Product Portfolio

7.10.3 Shengda Pharmaceutical Edoxaban API Production, Value, Price and Gross Margin (2020-2025)

7.10.4 Shengda Pharmaceutical Main Business and Markets Served

7.10.5 Shengda Pharmaceutical Recent Developments/Updates

7.11 Tianyu Pharm

7.11.1 Tianyu Pharm Edoxaban API Company Information

7.11.2 Tianyu Pharm Edoxaban API Product Portfolio

7.11.3 Tianyu Pharm Edoxaban API Production, Value, Price and Gross Margin (2020-2025)

7.11.4 Tianyu Pharm Main Business and Markets Served

7.11.5 Tianyu Pharm Recent Developments/Updates

8 Industry Chain and Sales Channels Analysis

8.1 Edoxaban API Industry Chain Analysis

8.2 Edoxaban API Raw Material Supply Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.3 Edoxaban API Production Mode & Process Analysis

8.4 Edoxaban API Sales and Marketing

8.4.1 Edoxaban API Sales Channels

8.4.2 Edoxaban API Distributors

8.5 Edoxaban API Customer Analysis

9 Edoxaban API Market Dynamics

9.1 Edoxaban API Industry Trends

9.2 Edoxaban API Market Drivers

9.3 Edoxaban API Market Challenges

9.4 Edoxaban API Market Restraints

10 Research Findings and Conclusion

11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Author List

11.4 Disclaimer

FEATURED COMPANIES

Tecoland

FCDA

Uquifa

Glenmark Life Sciences

AlchemyPharm

Athos Chemicals

Jigs Chemical

Shanghaizehan biopharma technology

Inner Mongolia Jingdong Pharmaceutical

Shengda Pharmaceutical

Tianyu Pharm

List of Tables

Table 1. Global Edoxaban API Market Value by Type, (US$ Million) & (2024 VS 2031)

Table 2. Global Edoxaban API Market Value by Application, (US$ Million) & (2024 VS 2031)

Table 3. Global Edoxaban API Production Capacity (MT) by Manufacturers in 2024

Table 4. Global Edoxaban API Production by Manufacturers (2020-2025) & (MT)

Table 5. Global Edoxaban API Production Market Share by Manufacturers (2020-2025)

Table 6. Global Edoxaban API Production Value by Manufacturers (2020-2025) & (US$ Million)

Table 7. Global Edoxaban API Production Value Share by Manufacturers (2020-2025)

Table 8. Global Key Players of Edoxaban API, Industry Ranking, 2023 VS 2024

Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Edoxaban API as of 2024)

Table 10. Global Market Edoxaban API Average Price by Manufacturers (USD/MT) & (2020-2025)

Table 11. Global Key Manufacturers of Edoxaban API, Manufacturing Base Distribution and Headquarters

Table 12. Global Key Manufacturers of Edoxaban API, Product Offered and Application

Table 13. Global Key Manufacturers of Edoxaban API, Date of Enter into This Industry

Table 14. Global Edoxaban API Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Edoxaban API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Edoxaban API Production Value (US$ Million) by Region (2020-2025)

Table 18. Global Edoxaban API Production Value Market Share by Region (2020-2025)

Table 19. Global Edoxaban API Production Value (US$ Million) Forecast by Region (2026-2031)

Table 20. Global Edoxaban API Production Value Market Share Forecast by Region (2026-2031)

Table 21. Global Edoxaban API Production Comparison by Region: 2020 VS 2024 VS 2031 (MT)

Table 22. Global Edoxaban API Production (MT) by Region (2020-2025)

Table 23. Global Edoxaban API Production Market Share by Region (2020-2025)

Table 24. Global Edoxaban API Production (MT) Forecast by Region (2026-2031)

Table 25. Global Edoxaban API Production Market Share Forecast by Region (2026-2031)

Table 26. Global Edoxaban API Market Average Price (USD/MT) by Region (2020-2025)

Table 27. Global Edoxaban API Market Average Price (USD/MT) by Region (2026-2031)

Table 28. Global Edoxaban API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (MT)

Table 29. Global Edoxaban API Consumption by Region (2020-2025) & (MT)

Table 30. Global Edoxaban API Consumption Market Share by Region (2020-2025)

Table 31. Global Edoxaban API Forecasted Consumption by Region (2026-2031) & (MT)

Table 32. Global Edoxaban API Forecasted Consumption Market Share by Region (2026-2031)

Table 33. North America Edoxaban API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (MT)

Table 34. North America Edoxaban API Consumption by Country (2020-2025) & (MT)

Table 35. North America Edoxaban API Consumption by Country (2026-2031) & (MT)

Table 36. Europe Edoxaban API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (MT)

Table 37. Europe Edoxaban API Consumption by Country (2020-2025) & (MT)

Table 38. Europe Edoxaban API Consumption by Country (2026-2031) & (MT)

Table 39. Asia Pacific Edoxaban API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (MT)

Table 40. Asia Pacific Edoxaban API Consumption by Region (2020-2025) & (MT)

Table 41. Asia Pacific Edoxaban API Consumption by Region (2026-2031) & (MT)

Table 42. Latin America, Middle East & Africa Edoxaban API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (MT)

Table 43. Latin America, Middle East & Africa Edoxaban API Consumption by Country (2020-2025) & (MT)

Table 44. Latin America, Middle East & Africa Edoxaban API Consumption by Country (2026-2031) & (MT)

Table 45. Global Edoxaban API Production (MT) by Type (2020-2025)

Table 46. Global Edoxaban API Production (MT) by Type (2026-2031)

Table 47. Global Edoxaban API Production Market Share by Type (2020-2025)

Table 48. Global Edoxaban API Production Market Share by Type (2026-2031)

Table 49. Global Edoxaban API Production Value (US$ Million) by Type (2020-2025)

Table 50. Global Edoxaban API Production Value (US$ Million) by Type (2026-2031)

Table 51. Global Edoxaban API Production Value Market Share by Type (2020-2025)

Table 52. Global Edoxaban API Production Value Market Share by Type (2026-2031)

Table 53. Global Edoxaban API Price (USD/MT) by Type (2020-2025)

Table 54. Global Edoxaban API Price (USD/MT) by Type (2026-2031)

Table 55. Global Edoxaban API Production (MT) by Application (2020-2025)

Table 56. Global Edoxaban API Production (MT) by Application (2026-2031)

Table 57. Global Edoxaban API Production Market Share by Application (2020-2025)

Table 58. Global Edoxaban API Production Market Share by Application (2026-2031)

Table 59. Global Edoxaban API Production Value (US$ Million) by Application (2020-2025)

Table 60. Global Edoxaban API Production Value (US$ Million) by Application (2026-2031)

Table 61. Global Edoxaban API Production Value Market Share by Application (2020-2025)

Table 62. Global Edoxaban API Production Value Market Share by Application (2026-2031)

Table 63. Global Edoxaban API Price (USD/MT) by Application (2020-2025)

Table 64. Global Edoxaban API Price (USD/MT) by Application (2026-2031)

Table 65. Tecoland Edoxaban API Company Information

Table 66. Tecoland Edoxaban API Specification and Application

Table 67. Tecoland Edoxaban API Production (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 68. Tecoland Main Business and Markets Served

Table 69. Tecoland Recent Developments/Updates

Table 70. FCDA Edoxaban API Company Information

Table 71. FCDA Edoxaban API Specification and Application

Table 72. FCDA Edoxaban API Production (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 73. FCDA Main Business and Markets Served

Table 74. FCDA Recent Developments/Updates

Table 75. UQUIFA Edoxaban API Company Information

Table 76. UQUIFA Edoxaban API Specification and Application

Table 77. UQUIFA Edoxaban API Production (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 78. UQUIFA Main Business and Markets Served

Table 79. UQUIFA Recent Developments/Updates

Table 80. Glenmark Life Sciences Edoxaban API Company Information

Table 81. Glenmark Life Sciences Edoxaban API Specification and Application

Table 82. Glenmark Life Sciences Edoxaban API Production (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 83. Glenmark Life Sciences Main Business and Markets Served

Table 84. Glenmark Life Sciences Recent Developments/Updates

Table 85. AlchemyPharm Edoxaban API Company Information

Table 86. AlchemyPharm Edoxaban API Specification and Application

Table 87. AlchemyPharm Edoxaban API Production (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 88. AlchemyPharm Main Business and Markets Served

Table 89. AlchemyPharm Recent Developments/Updates

Table 90. Athos Chemicals Edoxaban API Company Information

Table 91. Athos Chemicals Edoxaban API Specification and Application

Table 92. Athos Chemicals Edoxaban API Production (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 93. Athos Chemicals Main Business and Markets Served

Table 94. Athos Chemicals Recent Developments/Updates

Table 95. Jigs chemical Edoxaban API Company Information

Table 96. Jigs chemical Edoxaban API Specification and Application

Table 97. Jigs chemical Edoxaban API Production (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 98. Jigs chemical Main Business and Markets Served

Table 99. Jigs chemical Recent Developments/Updates

Table 100. Shanghaizehan biopharma technology Edoxaban API Company Information

Table 101. Shanghaizehan biopharma technology Edoxaban API Specification and Application

Table 102. Shanghaizehan biopharma technology Edoxaban API Production (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 103. Shanghaizehan biopharma technology Main Business and Markets Served

Table 104. Shanghaizehan biopharma technology Recent Developments/Updates

Table 105. Inner Mongolia Jingdong Pharmaceutical Edoxaban API Company Information

Table 106. Inner Mongolia Jingdong Pharmaceutical Edoxaban API Specification and Application

Table 107. Inner Mongolia Jingdong Pharmaceutical Edoxaban API Production (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 108. Inner Mongolia Jingdong Pharmaceutical Main Business and Markets Served

Table 109. Inner Mongolia Jingdong Pharmaceutical Recent Developments/Updates

Table 110. Shengda Pharmaceutical Edoxaban API Company Information

Table 111. Shengda Pharmaceutical Edoxaban API Specification and Application

Table 112. Shengda Pharmaceutical Edoxaban API Production (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 113. Shengda Pharmaceutical Main Business and Markets Served

Table 114. Shengda Pharmaceutical Recent Developments/Updates

Table 115. Tianyu Pharm Edoxaban API Company Information

Table 116. Tianyu Pharm Edoxaban API Specification and Application

Table 117. Tianyu Pharm Edoxaban API Production (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 118. Tianyu Pharm Main Business and Markets Served

Table 119. Tianyu Pharm Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Edoxaban API Distributors List

Table 123. Edoxaban API Customers List

Table 124. Edoxaban API Market Trends

Table 125. Edoxaban API Market Drivers

Table 126. Edoxaban API Market Challenges

Table 127. Edoxaban API Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Product Picture of Edoxaban API

Figure 2. Global Edoxaban API Market Value by Type, (US$ Million) & (2020-2031)

Figure 3. Global Edoxaban API Market Share by Type: 2024 VS 2031

Figure 4. Min Purity Less Than 98% Product Picture

Figure 5. Min Purity 98%-99% Product Picture

Figure 6. Min Purity More Than 99% Product Picture

Figure 7. Global Edoxaban API Market Value by Application, (US$ Million) & (2020-2031)

Figure 8. Global Edoxaban API Market Share by Application: 2024 VS 2031

Figure 9. Research

Figure 10. Pharmaceutical

Figure 11. Global Edoxaban API Production Value (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Edoxaban API Production Value (US$ Million) & (2020-2031)

Figure 13. Global Edoxaban API Production Capacity (MT) & (2020-2031)

Figure 14. Global Edoxaban API Production (MT) & (2020-2031)

Figure 15. Global Edoxaban API Average Price (USD/MT) & (2020-2031)

Figure 16. Edoxaban API Report Years Considered

Figure 17. Edoxaban API Production Share by Manufacturers in 2024

Figure 18. Global Edoxaban API Production Value Share by Manufacturers (2024)

Figure 19. Edoxaban API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. The Global 5 and 10 Largest Players: Market Share by Edoxaban API Revenue in 2024

Figure 21. Global Edoxaban API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 22. Global Edoxaban API Production Value Market Share by Region: 2020 VS 2024 VS 2031

Figure 23. Global Edoxaban API Production Comparison by Region: 2020 VS 2024 VS 2031 (MT)

Figure 24. Global Edoxaban API Production Market Share by Region: 2020 VS 2024 VS 2031

Figure 25. North America Edoxaban API Production Value (US$ Million) Growth Rate (2020-2031)

Figure 26. Europe Edoxaban API Production Value (US$ Million) Growth Rate (2020-2031)

Figure 27. China Edoxaban API Production Value (US$ Million) Growth Rate (2020-2031)

Figure 28. Japan Edoxaban API Production Value (US$ Million) Growth Rate (2020-2031)

Figure 29. India Edoxaban API Production Value (US$ Million) Growth Rate (2020-2031)

Figure 30. Global Edoxaban API Consumption by Region: 2020 VS 2024 VS 2031 (MT)

Figure 31. Global Edoxaban API Consumption Market Share by Region: 2020 VS 2024 VS 2031

Figure 32. North America Edoxaban API Consumption and Growth Rate (2020-2031) & (MT)

Figure 33. North America Edoxaban API Consumption Market Share by Country (2020-2031)

Figure 34. U.S. Edoxaban API Consumption and Growth Rate (2020-2031) & (MT)

Figure 35. Canada Edoxaban API Consumption and Growth Rate (2020-2031) & (MT)

Figure 36. Europe Edoxaban API Consumption and Growth Rate (2020-2031) & (MT)

Figure 37. Europe Edoxaban API Consumption Market Share by Country (2020-2031)

Figure 38. Germany Edoxaban API Consumption and Growth Rate (2020-2031) & (MT)

Figure 39. France Edoxaban API Consumption and Growth Rate (2020-2031) & (MT)

Figure 40. U.K. Edoxaban API Consumption and Growth Rate (2020-2031) & (MT)

Figure 41. Italy Edoxaban API Consumption and Growth Rate (2020-2031) & (MT)

Figure 42. Russia Edoxaban API Consumption and Growth Rate (2020-2031) & (MT)

Figure 43. Asia Pacific Edoxaban API Consumption and Growth Rate (2020-2031) & (MT)

Figure 44. Asia Pacific Edoxaban API Consumption Market Share by Region (2020-2031)

Figure 45. China Edoxaban API Consumption and Growth Rate (2020-2031) & (MT)

Figure 46. Japan Edoxaban API Consumption and Growth Rate (2020-2031) & (MT)

Figure 47. South Korea Edoxaban API Consumption and Growth Rate (2020-2031) & (MT)

Figure 48. China Taiwan Edoxaban API Consumption and Growth Rate (2020-2031) & (MT)

Figure 49. Southeast Asia Edoxaban API Consumption and Growth Rate (2020-2031) & (MT)

Figure 50. India Edoxaban API Consumption and Growth Rate (2020-2031) & (MT)

Figure 51. Latin America, Middle East & Africa Edoxaban API Consumption and Growth Rate (2020-2031) & (MT)

Figure 52. Latin America, Middle East & Africa Edoxaban API Consumption Market Share by Country (2020-2031)

Figure 53. Mexico Edoxaban API Consumption and Growth Rate (2020-2031) & (MT)

Figure 54. Brazil Edoxaban API Consumption and Growth Rate (2020-2031) & (MT)

Figure 55. Turkey Edoxaban API Consumption and Growth Rate (2020-2031) & (MT)

Figure 56. GCC Countries Edoxaban API Consumption and Growth Rate (2020-2031) & (MT)

Figure 57. Global Production Market Share of Edoxaban API by Type (2020-2031)

Figure 58. Global Production Value Market Share of Edoxaban API by Type (2020-2031)

Figure 59. Global Edoxaban API Price (USD/MT) by Type (2020-2031)

Figure 60. Global Production Market Share of Edoxaban API by Application (2020-2031)

Figure 61. Global Production Value Market Share of Edoxaban API by Application (2020-2031)

Figure 62. Global Edoxaban API Price (USD/MT) by Application (2020-2031)

Figure 63. Edoxaban API Value Chain

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Edoxaban Tosilate Tablets and Generic Drugs Market Research Report 2024

Global Oral Factor Xa Inhibitors Market Research Report 2024

Global Rivaroxaban Drugs Market Research Report 2024

Edoxaban Tosylate API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Factor Xa Inhibitors Market Research Report 2024

Global Direct Oral Anticoagulants DOACs Market Research Report 2024

Global Edoxaban Tosilate Orally Disintegrating Tablets Market Research Report 2024

Rivaroxaban API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Novel Oral Anticoagulants Drugs Market Insights Forecast to 2030

Apixaban API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Direct Oral Anticoagulant Market Insights Forecast to 2030

Heparin Sodium API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Dabigatran Market Insights Forecast to 2030

Global Anticoagulant Treatment Market Insights Forecast to 2030

Global Anticoagulant Drugs Market Insights Forecast to 2030

Global Enoxaparin Sodium APIs and Preparations Market Insights Forecast to 2030

Global Warfarin Sodium Tablets Market Research Report 2024

Global Intravenous Anticoagulants Market Research Report 2024

Apixaban Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

Report Code:

QYRE-Auto-27C2099

Published:

Mon Aug 09 00:00:00 UTC 2021

Est. Total

$46445.0